- Home
- WETH vs INTS Comparison
WETH vs INTS Comparison
Compare WETH & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WETH
- INTS
- Stock Information
- Founded
- WETH 1992
- INTS 2012
- Country
- WETH China
- INTS United States
- Employees
- WETH N/A
- INTS N/A
- Industry
- WETH
- INTS Biotechnology: Pharmaceutical Preparations
- Sector
- WETH
- INTS Health Care
- Exchange
- WETH Nasdaq
- INTS Nasdaq
- Market Cap
- WETH 10.9M
- INTS 9.4M
- IPO Year
- WETH N/A
- INTS 2023
- Fundamental
- Price
- WETH $0.88
- INTS $0.28
- Analyst Decision
- WETH
- INTS Strong Buy
- Analyst Count
- WETH 0
- INTS 3
- Target Price
- WETH N/A
- INTS $8.50
- AVG Volume (30 Days)
- WETH 40.4K
- INTS 2.8M
- Earning Date
- WETH 08-18-2025
- INTS 08-07-2025
- Dividend Yield
- WETH N/A
- INTS N/A
- EPS Growth
- WETH N/A
- INTS N/A
- EPS
- WETH 0.34
- INTS N/A
- Revenue
- WETH $41,024,264.00
- INTS N/A
- Revenue This Year
- WETH N/A
- INTS N/A
- Revenue Next Year
- WETH N/A
- INTS N/A
- P/E Ratio
- WETH $2.62
- INTS N/A
- Revenue Growth
- WETH 2.86
- INTS N/A
- 52 Week Low
- WETH $0.76
- INTS $0.28
- 52 Week High
- WETH $3.62
- INTS $5.10
- Technical
- Relative Strength Index (RSI)
- WETH 36.06
- INTS 34.41
- Support Level
- WETH $0.77
- INTS $0.28
- Resistance Level
- WETH $0.98
- INTS $0.36
- Average True Range (ATR)
- WETH 0.06
- INTS 0.07
- MACD
- WETH -0.00
- INTS 0.01
- Stochastic Oscillator
- WETH 44.92
- INTS 1.85
About WETH Wetouch Technology Inc.
Wetouch Technology Inc is a touch panel supplier focused on R & D, production and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots and charging stations. The company sells touchscreen products both domestically in China and internationally, covering the majority of areas in China, Taiwan, South Korea, and Germany.
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.